Striatal β-amyloid deposition in Parkinson disease with Dementia

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 2, 2008, Pages 155-161

  Kalaitzakis, Michail E ^a   Graeber, Manuel B ^a   Gentleman, Stephen M ^a   Pearce, Ronald K B ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Amyloid deposition; Dementia; Parkinson disease; Striatum

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; TAU PROTEIN; TYROSINE 3 MONOOXYGENASE;

ADULT; AGED; ARTICLE; CORPUS STRIATUM; DEMENTIA; FEMALE; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PARKINSON DISEASE; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN; CORPUS STRIATUM; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TAU PROTEINS; TYROSINE 3-MONOOXYGENASE;

EID: 42949123971     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31816362aa     Document Type: Article

References (45)

1. Lee CS, Schulzer M, Mak EK, et al. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 1994;117:501-7 (Pubitemid 24225898)
2. Aarsland D, Karlsen K. Neuropsychiatric aspects of Parkinsoǹs disease. Curr Psychiatry Rep 1999;1:61-68
3. Aarsland D, Tandberg E, Larsen JP, Cummings JL. Frequency of dementia in Parkinson disease. Arch Neurol. 1996;53:538-42 (Pubitemid 26177134)
4. Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinsoǹs disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999;14:866-74 (Pubitemid 29495548)
5. Fearnley JM, Lees AJ. Ageing and Parkinsoǹs disease: Substantia nigra regional selectivity. Brain 1991;114:2283-2301
6. Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinsoǹs disease. Acta Neuropathol (Berl) 2000;100:285-90 (Pubitemid 30456155)
7. Mattila PM, Roytta M, Torikka H, Dickson DW, Rinne JO. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinsoǹs disease. Acta Neuropathol (Berl) 1998;95:576-82
8. Kovari E, Gold G, Herrmann FR, et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinsoǹs disease. Acta Neuropathol (Berl) 2003;106:83-88 (Pubitemid 36806171)
9. Harding AJ, Halliday GM. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (Berl) 2001;102:355-63 (Pubitemid 32894706)
10. Hurtig HI, Trojanowski JQ, Galvin J, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinsoǹs disease. Neurology 2000;54:1916-21 (Pubitemid 30327112)
11. Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 2002;52:205-10 (Pubitemid 34810601)
12. Liang T, Noorigian JV, Duda JE. Does striatal pathology distinguish DLB from PDD? Mov Disord 2006;21:S69-70
13. Jellinger KA, Attems J. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol (Berl) 2006;112:253-60 (Pubitemid 44275880)
14. Nakano K, Kayahara T, Tsutsumi T, Ushiro H. Neural circuits and functional organization of the striatum. J Neurol 2000;247:V1-15
15. Vonsattel JP, Aizawa H, Ge P, et al. An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 1995;54:42-56
16. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 2006;112:389-404 (Pubitemid 44469160)
17. Daniel SE, Lees AJ. Parkinsoǹs Disease Society Brain Bank, London: Overview and research. J Neural Transm Suppl 1993;39:165-72 (Pubitemid 23216938)
18. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-24 (Pubitemid 26374873)
19. thed. Washington, DC: American Psychiatric Press, 1994.
20. Litvan I, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: A clinicopathologic study. Arch Neurol 1998;55:969-78 (Pubitemid 28335116)
21. Papapetropoulos S, Lieberman A, Gonzales J, Mash DC. Can Alzheimer̀s type pathology influence the clinical phenotype of Parkinsoǹs disease? Acta Neurol Scand 2005;111:353-59 (Pubitemid 40705304)
22. Papapetropoulos S, Gonzalez J, Lieberman A, Villar JM, Mash DC. Dementia in Parkinsoǹs disease: A post-mortem study in a population of brain donors. Int J Geriatr Psychiatry 2005;20:418-22 (Pubitemid 40716333)
23. Parkkinen L, Kauppinen T, Pirttila T, Autere JM, Alafuzoff I. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 2005;57:82-91 (Pubitemid 40053318)
24. Brilliant MJ, Elble RJ, Ghobrial M, Struble RG. The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer̀s disease. Neuropathol Appl Neurobiol 1997;23:322-25 (Pubitemid 27352843)
25. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: Later-developing dementia and loss of the levodopa response. Arch Neurol 2002;59:102-12 (Pubitemid 34052562)
26. Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinsoǹs disease: A prospective, community-based study. Ann Neurol 2005;58:773-76 (Pubitemid 41552553)
27. Forno LS, Norville RL. Ultrastructure of neostriatum in Huntingtoǹs and Parkinsoǹs disease. Adv Neurol 1979;23:123-35
28. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer̀s disease. Cereb Cortex 1991;1:103-16
29. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer̀s disease. Neurology 1992;42:631-39
30. Terry RD. The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis. J Neuropathol Exp Neurol 1996;55:1023-25 (Pubitemid 26338013)
31. Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G. The cause of neuronal degeneration in Alzheimer̀s disease. Prog Neurobiol 2000;60:139-65
32. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer̀s disease. Neurology 1992;42:1681-88
33. Gearing M, Wilson RW, Unger ER, et al. Amyloid precursor protein (APP) in the striatum in Alzheimer̀s disease: An immunohistochemical study. J Neuropathol Exp Neurol 1993;52:22-30 (Pubitemid 23016636)
34. Suenaga T, Hirano A, Llena JF, Yen SH, Dickson DW. Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer̀s disease. Acta Neuropathol (Berl) 1990;80:280-86 (Pubitemid 20220543)
35. Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002;58:1791-1800 (Pubitemid 34663580)
36. Colloby SJ, Williams ED, Burn DJ, Lloyd JJ, McKeith IG, O'Brien JT. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinsoǹs disease with and without dementia assessed using 123I-FP-CIT SPECT. Eur J Nucl Med Mol Imaging 2005;32:1176-85 (Pubitemid 41355944)
37. Wise S. The role of the basal ganglia in procedural memory. Semin Neurosci 1996;8:39-46
38. Nakano K. Neural circuits and topographic organization of the basal ganglia and related regions. Brain Dev 2000;22 Suppl 1:S5-16 (Pubitemid 30662456)
39. Knowlton BJ, Mangels JA, Squire LR. A neostriatal habit learning system in humans. Science 1996;273:1399-1402 (Pubitemid 26296530)
40. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997;275:1593-99 (Pubitemid 27120526)
41. Newman R, Winans SS. An experimental study of the ventral striatum of the golden hamster. II. Neuronal connections of the olfactory tubercle. J Comp Neurol 1980;191:193-212 (Pubitemid 10076662)
42. Pletnikova O, West N, Lee MK, et al. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 2005;26:1183-92 (Pubitemid 40726011)
43. Galpern WR, Lang AE. Interface between tauopathies and synucleinopathies: A tale of two proteins. Ann Neurol 2006;59:449-58 (Pubitemid 43358065)
44. Iseki E, Togo T, Suzuki K, et al. Dementia with Lewy bodies from the perspective of tauopathy. Acta Neuropathol (Berl) 2003;105:265-70 (Pubitemid 36798819)
45. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer̀s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer̀s disease. Neurology 1991;41:479-86